Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108251 · ClinicalTrials.gov registry record · Phase 4
Aldosterone Antagonism in Diastolic Heart Failure
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT00108251 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 48 participants.
The verdict
NCT00108251, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine whether eplerenone has a beneficial effect on improving exercise ability in patients with diastolic heart failure.
Interventions
- DRUG Placebo
- DRUG Eplerenone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108251
The ClinicalTrials.gov registry entry for NCT00108251 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00108251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108251 about?
NCT00108251 is a clinical study titled "Aldosterone Antagonism in Diastolic Heart Failure". The primary purpose of this study is to determine whether eplerenone has a beneficial effect on improving exercise ability in patients with diastolic heart failure.
What is the current status of trial NCT00108251?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2004-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00108251?
The interventions under investigation include: Placebo (DRUG), Eplerenone (DRUG).
Who is sponsoring clinical trial NCT00108251?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.